Butler Matthew G, Dagenais Susan L, Rockson Stanley G, Glover Thomas W
Department of Human Genetics, University of Michigan, Ann Arbor, Michigan 48109-0618, USA.
Am J Med Genet A. 2007 Jun 1;143A(11):1212-7. doi: 10.1002/ajmg.a.31703.
Milroy disease, also known as primary congenital lymphedema, is a hereditary form of lymphedema with autosomal dominant inheritance. Individuals with Milroy disease are typically characterized by congenital onset of lymphedema of the lower limbs due to hypoplasia of the lymphatic vessels. The genetic basis of most cases of Milroy disease has not been established, although mutations in the vascular endothelial growth factor receptor VEGFR3 (FLT-4) are responsible for some cases with 17 mutations described to date. In this report, we describe a novel VEGFR3 mutation in exon 22 in a four-generation family in which congenital lymphedema segregates in an autosomal dominant manner. In addition to lymphedema, affected family members had other clinical manifestations associated with Milroy disease including hydrocele, ski jump toenails, large caliber veins, and subcutaneous thickening. We screened VEGFR3 for mutations which revealed a novel 3059A>T transversion in exon 22 resulting in Q1020L missense mutation in the second tyrosine kinase domain of VEGFR3. This mutant allele segregated with lymphedema among affected individuals with incomplete penetrance. This is the first report of an exon 22 mutation in Milroy disease.
米尔罗伊病,也称为原发性先天性淋巴水肿,是一种具有常染色体显性遗传的遗传性淋巴水肿形式。患有米尔罗伊病的个体通常表现为由于淋巴管发育不全导致下肢先天性淋巴水肿。尽管血管内皮生长因子受体VEGFR3(FLT - 4)的突变导致了一些病例(迄今为止已描述了17种突变),但大多数米尔罗伊病病例的遗传基础尚未明确。在本报告中,我们描述了一个四代家族中外显子22处的一种新的VEGFR3突变,其中先天性淋巴水肿以常染色体显性方式分离。除淋巴水肿外,受影响的家庭成员还有与米尔罗伊病相关的其他临床表现,包括鞘膜积液、“滑雪跳”状趾甲、大口径静脉和皮下增厚。我们对VEGFR3进行了突变筛查,发现外显子22处有一个新的3059A>T颠换,导致VEGFR3第二个酪氨酸激酶结构域出现Q1020L错义突变。这个突变等位基因在受影响个体中与淋巴水肿分离,具有不完全外显率。这是关于米尔罗伊病中外显子22突变的首次报告。